Artivion, Inc. (AORT)
21.78
-0.09
(-0.41%)
USD |
NYSE |
Oct 16, 16:00
21.69
-0.09
(-0.41%)
After-Hours: 20:00
Artivion Cash and Short Term Investments (Quarterly) : 77.32M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 77.32M |
| March 31, 2026 | 55.76M |
| December 31, 2025 | 64.91M |
| September 30, 2025 | 73.43M |
| June 30, 2025 | 53.48M |
| March 31, 2025 | 37.69M |
| December 31, 2024 | 53.46M |
| September 30, 2024 | 56.17M |
| June 30, 2024 | 55.02M |
| March 31, 2024 | 51.12M |
| December 31, 2023 | 58.94M |
| September 30, 2023 | 53.48M |
| June 30, 2023 | 48.78M |
| March 31, 2023 | 30.77M |
| December 31, 2022 | 39.35M |
| September 30, 2022 | 37.57M |
| June 30, 2022 | 40.38M |
| March 31, 2022 | 51.41M |
| December 31, 2021 | 55.01M |
| September 30, 2021 | 65.12M |
| June 30, 2021 | 51.03M |
| March 31, 2021 | 57.10M |
| December 31, 2020 | 61.96M |
| September 30, 2020 | 64.64M |
| June 30, 2020 | 126.12M |
| Date | Value |
|---|---|
| March 31, 2020 | 63.88M |
| December 31, 2019 | 34.29M |
| September 30, 2019 | 37.18M |
| June 30, 2019 | 40.26M |
| March 31, 2019 | 41.08M |
| December 31, 2018 | 42.24M |
| September 30, 2018 | 35.31M |
| June 30, 2018 | 25.72M |
| March 31, 2018 | 27.39M |
| December 31, 2017 | 40.75M |
| September 30, 2017 | 55.01M |
| June 30, 2017 | 53.25M |
| March 31, 2017 | 59.60M |
| December 31, 2016 | 57.34M |
| September 30, 2016 | 54.88M |
| June 30, 2016 | 47.69M |
| March 31, 2016 | 45.64M |
| December 31, 2015 | 38.42M |
| September 30, 2015 | 39.34M |
| June 30, 2015 | 35.94M |
| March 31, 2015 | 33.24M |
| December 31, 2014 | 34.26M |
| September 30, 2014 | 30.75M |
| June 30, 2014 | 36.84M |
| March 31, 2014 | 38.45M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Alphatec Holdings, Inc. | 118.66M |
| Glaukos Corp. | 286.23M |
| TransMedics Group, Inc. | 472.68M |
| Embecta Corp. | 218.20M |
| Abbott Laboratories | 5.603B |